Breuer, Johanna
Korpos, Eva
Hannocks, Melanie-Jane
Schneider-Hohendorf, Tilman
Song, Jian
Zondler, Lisa
Herich, Sebastian
Flanagan, Ken
Korn, Thomas
Zarbock, Alexander
Kuhlmann, Tanja
Sorokin, Lydia
Wiendl, Heinz
Schwab, Nicholas
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (CRC128 B1, CRC128 B1, CRC128, CRC128, CRC128, CRC128)
IZKF Münster
Competence Network for Multiple Sclerosis
Article History
Received: 28 March 2018
Accepted: 10 August 2018
First Online: 22 August 2018
Ethics approval and consent to participate
: All animal procedures were approved by and conducted in accordance with the laws and the regulations of the regulatory authorities for animal care and scientific use in North Rhine-Westphalia, Germany. Studies on human samples were approved by the local ethics committee and performed according to the Declaration of Helsinki.
: Not applicable.
: JB, EK, MJH, TSH, JS, LZ, SH, TKo, AZ, and LS have nothing to declare. KF is an employee of Prothena Biosciences Inc. TKu has received honoraria from Novartis and EXCEMED. HW has received honoraria and consultation fees from Biogen. NS has received travel support from Sanofi-Genzyme and Novartis.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.